Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood
Recurrence of hepatitis B virus-related hepatocellular carcinoma (HBV-HCC) after liver transplant (LT) is mediated by circulating tumour cells (CTCs) and exacerbated by the immunosuppressants required to prevent graft rejection. To circumvent the effects of immunosuppressants, we developed immunosup...
Saved in:
Main Author: | Lin M. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/90274 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Immunosuppressive Drug Resistant Armored TCR T cells for immune-therapy of HCC in liver transplant patients
by: MORTEZA HAFEZI, et al.
Published: (2021) -
STRATEGIES TO INCREASE THE EFFICACY OF T-CELL RECEPTOR (TCR) T CELL THERAPY AGAINST HBV-RELATED HCC
by: LIN MEIYIN
Published: (2023) -
CHARACTERIZATION OF HEPATITIS B VIRUS (HBV) IN HEPATOCELLULAR CARCINOMA (HCC) PATIENTS
by: TOH SOO TING
Published: (2013) -
MUTATION IN THE SURFACE AND CORE GENE OF HBV DNA IN HCC PATIENTS NEGATIVE FOR THE SURFACE ANTIGEN
by: LIM CHOON ANN
Published: (2020) -
Engineered lysins with customized lytic activities against enterococci and staphylococci
by: Hana Sakina Muhammad Jai, et al.
Published: (2021)